MARKET

MOLN

MOLN

MOLECULAR PARTNERS AG
NASDAQ
3.840
-0.010
-0.26%
Closed 11:09 05/16 EDT
OPEN
3.890
PREV CLOSE
3.850
HIGH
3.890
LOW
3.840
VOLUME
1.07K
TURNOVER
--
52 WEEK HIGH
12.70
52 WEEK LOW
3.360
MARKET CAP
141.55M
P/E (TTM)
-2.1943
1D
5D
1M
3M
1Y
5Y
1D
Molecular Partners reports Q1 results
Seeking Alpha · 1d ago
CORRECTION: Molecular Partners Q1 EPS $(0.51)
Benzinga · 1d ago
Molecular Partners Q1 EPS $0.51
Benzinga · 1d ago
Molecular Partners Reports Strong Q1 2025 Financials and Clinical Progress
TipRanks · 1d ago
MOLECULAR PARTNERS OUTLOOK FY OPERATING EXPENSES CHF 55-65 MILLION
Reuters · 1d ago
Molecular Partners’ Promising MP0533 Program Drives Buy Recommendation
TipRanks · 2d ago
Molecular Partners: Sluggish Progress But Worth Monitoring (Rating Downgrade)
Seeking Alpha · 4d ago
Weekly Report: what happened at MOLN last week (0505-0509)?
Weekly Report · 5d ago
More
About MOLN
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

Webull offers Molecular Partners AG (ADR) stock information, including NASDAQ: MOLN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MOLN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MOLN stock methods without spending real money on the virtual paper trading platform.